EP0708658A4 - Vaccin contenant un cytomegalovirus de recombinaison - Google Patents
Vaccin contenant un cytomegalovirus de recombinaisonInfo
- Publication number
- EP0708658A4 EP0708658A4 EP94915386A EP94915386A EP0708658A4 EP 0708658 A4 EP0708658 A4 EP 0708658A4 EP 94915386 A EP94915386 A EP 94915386A EP 94915386 A EP94915386 A EP 94915386A EP 0708658 A4 EP0708658 A4 EP 0708658A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- cytomegalovirus vaccine
- recombinant cytomegalovirus
- recombinant
- vaccine
- cytomegalovirus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 241000701022 Cytomegalovirus Species 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
- C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
- C12N2710/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4897893A | 1993-04-16 | 1993-04-16 | |
US48978 | 1993-04-16 | ||
PCT/US1994/004180 WO1994023744A1 (fr) | 1993-04-16 | 1994-04-15 | Vaccin contenant un cytomegalovirus de recombinaison |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0708658A1 EP0708658A1 (fr) | 1996-05-01 |
EP0708658A4 true EP0708658A4 (fr) | 1997-05-21 |
Family
ID=21957451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP94915386A Withdrawn EP0708658A4 (fr) | 1993-04-16 | 1994-04-15 | Vaccin contenant un cytomegalovirus de recombinaison |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0708658A4 (fr) |
CA (1) | CA2160583A1 (fr) |
WO (1) | WO1994023744A1 (fr) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5591439A (en) * | 1989-03-24 | 1997-01-07 | The Wistar Institute Of Anatomy And Biology | Recombinant cytomegalovirus vaccine |
US5997878A (en) * | 1991-03-07 | 1999-12-07 | Connaught Laboratories | Recombinant poxvirus-cytomegalovirus, compositions and uses |
AU2809897A (en) | 1996-04-23 | 1997-11-12 | Wistar Institute Of Anatomy And Biology, The | Novel human cytomegalovirus dna constructs and uses therefor |
AU6150498A (en) * | 1997-02-07 | 1998-08-26 | Wistar Institute, The | Methods and compositions for the inhibition of interleukin-12 production |
CA2330208A1 (fr) | 1998-05-29 | 1999-12-02 | Thomas Jefferson University | Compositions et methodes utilisees pour modifier des populations de cellules souches hematopoietiques chez des mammiferes |
US6420545B1 (en) | 1999-05-24 | 2002-07-16 | The Trustees Of The University Of Pennsylvania | CD4-independent HIV envelope proteins as vaccines and therapeutics |
US6846486B1 (en) | 2000-02-24 | 2005-01-25 | Advanced Biotherapy Concepts, Inc. | Method of treating allergy by administering an anti-histamine antibody |
EP2184296A1 (fr) | 2000-07-19 | 2010-05-12 | Advanced Research And Technology Institute, Inc. | Facteur de croissance fibroblastique (fgf23) et ses méthodes d'utilisation |
EP1404713A4 (fr) | 2001-05-24 | 2004-09-22 | Human Dna Technology Inc | Nouvel analogue du facteur de croissance des keratinocytes-2 du follicule pileux |
AUPR593101A0 (en) | 2001-06-26 | 2001-07-19 | Council Of The Queensland Institute Of Medical Research, The | Cytomegalovirus t cell epitopes |
US7176278B2 (en) | 2001-08-30 | 2007-02-13 | Biorexis Technology, Inc. | Modified transferrin fusion proteins |
CN1713920A (zh) | 2002-08-30 | 2005-12-28 | 比奥雷克西斯药物公司 | 被修饰的转铁蛋白融合蛋白 |
ES2537514T3 (es) | 2003-04-04 | 2015-06-09 | Incyte Corporation | Composiciones, métodos y kits relacionados con la escisión de HER-2 |
EP2295588B1 (fr) | 2004-05-27 | 2018-03-07 | The Trustees Of The University Of Pennsylvania | Nouvel antigène artificiel présentant des cellules et utilisations associées |
US7608433B2 (en) | 2005-02-09 | 2009-10-27 | Idexx Laboratories | Method of detection of classical swine fever |
MX2008006313A (es) | 2005-11-15 | 2008-11-06 | Philadelphia Children Hospital | Metodos y composiciones para modular la hemostasia. |
DE602005023550D1 (de) | 2005-12-14 | 2010-10-21 | Licentia Ltd | Verwendungen eines neurotrophischen Faktors |
EP1986681A4 (fr) | 2006-02-23 | 2010-08-04 | Philadelphia Children Hospital | Compositions et méthodes pour moduler une hémostase au moyen de différentes formes de facteur v activé |
AU2007331195A1 (en) | 2006-12-12 | 2008-06-19 | Biorexis Pharmaceutical Corporation | Transferrin fusion protein libraries |
FI20070808A0 (fi) | 2007-10-25 | 2007-10-25 | Mart Saarma | GDNF:n silmukointivariantit ja niiden käytöt |
FI20080326A0 (fi) | 2008-04-30 | 2008-04-30 | Licentia Oy | Neurotroofinen tekijä MANF ja sen käytöt |
US8557762B2 (en) | 2008-11-21 | 2013-10-15 | The Children's Hospital Of Philadelphia | Snake factor V and methods of use thereof as a procoagulant |
WO2012074868A2 (fr) | 2010-12-03 | 2012-06-07 | Ms Technologies, Llc | Expression optimisée de molécules d'acide nucléique codant pour la résistance au glyphosate dans cellules végétales |
EP2760887A4 (fr) | 2011-09-30 | 2015-06-10 | Philadelphia Children Hospital | Compositions et procédés pour moduler l'homéostasie |
US9783817B2 (en) | 2013-03-04 | 2017-10-10 | Arkansas State University | Methods of expressing and detecting activity of expansin in plant cells |
WO2014191630A2 (fr) | 2013-05-28 | 2014-12-04 | Helsingin Yliopisto | Modèle animal non humain codant pour un gène manf non fonctionnel |
US20200390814A1 (en) | 2018-02-02 | 2020-12-17 | Arizona Board Of Regents On Behalf Of Arizona State University | Dna-chimeric antigen receptor t cells for immunotherapy |
CA3197730A1 (fr) | 2020-10-15 | 2022-04-21 | F. Hoffman-La Roche Ag | Constructions d'acide nucleique pour transcription de va-arn |
KR20230085170A (ko) | 2020-10-15 | 2023-06-13 | 에프. 호프만-라 로슈 아게 | 동시 유전자 활성화를 위한 핵산 구조체 |
WO2023198685A1 (fr) | 2022-04-13 | 2023-10-19 | F. Hoffmann-La Roche Ag | Procédé de détermination de génomes d'aav |
WO2023227438A1 (fr) | 2022-05-23 | 2023-11-30 | F. Hoffmann-La Roche Ag | Procédé raman de différenciation d'un sérotype de particules aav et d'un état de chargement de particules aav |
WO2023232922A1 (fr) | 2022-06-03 | 2023-12-07 | F. Hoffmann-La Roche Ag | Procédé de production de particules d'aav recombinées |
WO2024013239A1 (fr) | 2022-07-14 | 2024-01-18 | F. Hoffmann-La Roche Ag | Procédé de production de particules de virus adéno-associé recombinant |
WO2024056561A1 (fr) | 2022-09-12 | 2024-03-21 | F. Hoffmann-La Roche Ag | Procédé de séparation de particules de vaa pleines et vides |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990000062A1 (fr) * | 1988-07-01 | 1990-01-11 | The Children's Hospital, Incorporated | Reconnaissance de fragments provenant de cytomegalovirus a l'aide d'anticorps |
WO1990006771A1 (fr) * | 1988-12-12 | 1990-06-28 | The Children's Hospital, Incorporated | Fragments proteolytiques obtenus a partir du complexe i de glycoproteines de cytomegalovirus humain |
EP0389286A2 (fr) * | 1989-03-24 | 1990-09-26 | The Wistar Institute Of Anatomy And Biology | Vaccin recombinant contre le virus cytomégalo |
WO1990011302A1 (fr) * | 1989-03-24 | 1990-10-04 | University Of Iowa Research Foundation | Sites de reconnaissance de cellules t et anticorps sur des glycoproteines |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA858044B (en) * | 1984-11-01 | 1987-05-27 | American Home Prod | Oral vaccines |
-
1994
- 1994-04-15 WO PCT/US1994/004180 patent/WO1994023744A1/fr not_active Application Discontinuation
- 1994-04-15 CA CA002160583A patent/CA2160583A1/fr not_active Abandoned
- 1994-04-15 EP EP94915386A patent/EP0708658A4/fr not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990000062A1 (fr) * | 1988-07-01 | 1990-01-11 | The Children's Hospital, Incorporated | Reconnaissance de fragments provenant de cytomegalovirus a l'aide d'anticorps |
WO1990006771A1 (fr) * | 1988-12-12 | 1990-06-28 | The Children's Hospital, Incorporated | Fragments proteolytiques obtenus a partir du complexe i de glycoproteines de cytomegalovirus humain |
EP0389286A2 (fr) * | 1989-03-24 | 1990-09-26 | The Wistar Institute Of Anatomy And Biology | Vaccin recombinant contre le virus cytomégalo |
WO1990011302A1 (fr) * | 1989-03-24 | 1990-10-04 | University Of Iowa Research Foundation | Sites de reconnaissance de cellules t et anticorps sur des glycoproteines |
Non-Patent Citations (4)
Title |
---|
BERENCSI ET AL: "HUMAN CYTOMEGALOVIRUS (HCMV) GLYCOPROTEIN-B (GB)-SPECIFIC CELL-MEDIATED IMMUNITY IN EXPERIMENTAL ANIMALS", ACTA MICROBIOLOGICA HUNGARICA, vol. 38, 1991, pages 170 - 171, XP000645013 * |
BERENCSI ET AL: "MURINE CYTOTOXIC T CELL RESPONSE SPECIFIC FOR HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B (GB) INDUCED BY ADENOVIRUS AND VACCINIA VIRUS RECOMBINANTS EXPRESSING GB", JOURNAL OF GENERAL VIROLOGY, vol. 74, November 1993 (1993-11-01), pages 2507 - 2512, XP002026070 * |
LIU ET AL: "THE N-TERIMINAL 513 AMINO ACIDS OF THE ENVELOPE GLYCOPROTEIN GB OF HUMAN CYTOMEGALOVIRUS STIMLATES BOTH B- AND T-CELL IMMUNE RESPONSES IN HUMANS", JOURNAL OF VIROLOGY, vol. 65, no. 3, March 1991 (1991-03-01), pages 1644 - 1648, XP000645036 * |
See also references of WO9423744A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP0708658A1 (fr) | 1996-05-01 |
WO1994023744A1 (fr) | 1994-10-27 |
CA2160583A1 (fr) | 1994-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0708658A4 (fr) | Vaccin contenant un cytomegalovirus de recombinaison | |
GB9115909D0 (en) | Recombinant dna | |
AP9300541A0 (en) | Vaccines | |
AP9300530A0 (en) | Vaccines | |
CZ197595A3 (en) | Vaccine preparations | |
ZA947828B (en) | Vaccines | |
GB9325496D0 (en) | Vaccines | |
IL101639A0 (en) | Recombinant influenza vaccines | |
EP0710120A4 (fr) | Suipoxvirus recombine | |
AU6715094A (en) | Recombinant vaccine | |
GB9215233D0 (en) | Vaccines | |
AU2347692A (en) | Recombinant viral vaccine | |
GB9322702D0 (en) | Vaccines | |
GB9214871D0 (en) | Vaccines | |
GB9213559D0 (en) | Vaccines | |
GB9201023D0 (en) | Vaccines | |
ZA948729B (en) | Vaccines | |
ZA93919B (en) | Vaccines | |
GB9226768D0 (en) | Vaccines | |
GB9304962D0 (en) | Recombinant virus | |
ZA945843B (en) | Recombinant adenovirus vaccines | |
GB9220010D0 (en) | Recombinant virus | |
GB9211081D0 (en) | Vaccines | |
GB9106568D0 (en) | Recombinant antigen | |
GB9324964D0 (en) | Viral vaccines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19951106 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
RHK1 | Main classification (correction) |
Ipc: C12N 15/00 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19970404 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
17Q | First examination report despatched |
Effective date: 19990316 |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20030730 |